第一单位：
Department of Oncology, Gynecologic Oncology, KU Leuven (University of Leuven), Leuven, Belgium.
作者：
Tine,Cuppens [1]
;
Daniela,Annibali [1]
;
An,Coosemans [2]
;
Jone,Trovik [3]
;
Natalja,Ter Haar [4]
;
Eva,Colas [5]
;
Angel,Garcia-Jimenez [6]
;
Koen,Van de Vijver [7]
;
Roy P M,Kruitwagen [8]
;
Mariël,Brinkhuis [9]
;
Michal,Zikan [10]
;
Pavel,Dundr [11]
;
Jutta,Huvila [12]
;
Olli,Carpén [13]
;
Johannes,Haybaeck [14]
;
Farid,Moinfar [15]
;
Helga B,Salvesen [3]
;
Maciej,Stukan [16]
;
Carole,Mestdagh [17]
;
Ronald P,Zweemer [18]
;
Leonardus F,Massuger [19]
;
Michael R,Mallmann [20]
;
Eva,Wardelmann [21]
;
Miriam,Mints [22]
;
Godelieve,Verbist [23]
;
Debby,Thomas [24]
;
Ellen,Gommé [24]
;
Els,Hermans [24]
;
Philippe,Moerman [25]
;
Tjalling,Bosse [4]
;
Frédéric,Amant [26]
作者单位：
Department of Oncology, Gynecologic Oncology, KU Leuven (University of Leuven), Leuven, Belgium.
[1]
Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, ImmunOvar Research Group, KU Leuven (University of Leuven), Leuven, Belgium.;Department of Gynaecology and Obstetrics, Leuven Cancer Institute, UZ Leuven, Leuven, Belgium.
[2]
Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.;Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
[3]
Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
[4]
Biomedical Research Group in Gynecology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.;Department of Pathology and Molecular Genetics/Oncologic Pathology Group, Arnau de Vilanova University Hospital, University of Lleida, IRB Lleida, Lleida, Spain.
[5]
Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain.
[6]
Department of Pathology, GROW - School for Oncology & Developmental Biology, Maastricht University Medical Centre, the Netherlands.
[7]
Department of Gynecology and Obstetrics, GROW - School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.
[8]
Laboratory for Pathology Oost Nederland, Hengelo, The Netherlands.
[9]
Department of Obstetrics and Gynecology, Gynecological Oncology Center, Charles University in Prague - 1st Faculty of Medicine and General University Hospital in Prague, Czech Republic.
[10]
Department of Pathology, Charles University in Prague - 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
[11]
Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland.
[12]
Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland.;Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
[13]
Institute of Pathology, Medical University of Graz, Graz, Austria.
[14]
Department of Pathology, Hospital of the Sisters of Charity, Linz, Austria.
[15]
Department of Gynecologic Oncology, Oncology Center, Provincial Hospitals Gdynia, Gdynia, Poland.
[16]
Institut de Pathologie et de Génétique, Brussels, Belgium.
[17]
Department of Gynecological Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.
[18]
Department of Obstetrics and Gynecology, Radboud University Medical Centre Nijmegen, Nijmegen, the Netherlands.
[19]
Department of Obstetrics and Gynecology, University of Bonn, Bonn, Germany.
[20]
Institute of Pathology, University Hospital Cologne, Cologne, Germany.
[21]
Department of Women's and Children's Health, Karolinska Institutet at Karolinska University Hospital Solna, Stockholm, Sweden.
[22]
Department of Development and Regeneration, KU Leuven (University of Leuven), Leuven, Belgium.
[23]
Department of Oncology, Trace Platform, KU Leuven (University of Leuven) - UZ Leuven, Leuven, Belgium.
[24]
Department of Pathology, UZ Leuven - KU Leuven (University of Leuven), Leuven, Belgium.
[25]
Department of Oncology, Gynecologic Oncology, KU Leuven (University of Leuven), Leuven, Belgium. frederic.amant@uzleuven.be.;Centre for Gynecologic Oncology Amsterdam (CGOA), Antoni Van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands.
[26]
DOI
10.1158/1078-0432.CCR-16-2149
PMID
28232476
发布时间
2021-12-04
换一批
